Use of D-Chiro-inositol in Male Functional Hypogonadism Associated With Sexual Dysfunction

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age50-75
SponsorCardarelli Hospital

About this trial

A prospective, uncontrolled, non-pharmacological interventional study conducted on men with functional or borderline hypogonadism, aimed at evaluating, after 3 months of supplementation with D-Chiro-inositol, changes in hormonal profile and sexual function.

Eligibility criteria

Qualifiers

Men aged between 50 and 75

Affected by functional hypogonadism associated with male aging

Disqualifiers

Elevated ferritin, PRL, and/or elevated CRP values; diagnosis of primary hypogonadism; diagnosis of organic hypogonadotropic hypogonadism or secondary to other ongoing acute or chronic pathologies; presence of other pituitary deficits.

Alcohol use and/or drug abuse, recent hormone treatment, smoking, systemic or endocrine diseases, infection of the male accessory glands, medical history of cryptorchidism or varicocele, and micro-orchidism.

Trial design

Treatments tested in this trial

  • D-chiro-inositol

Treatment groups

35 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators